drugset
drugset / Trial / NCT02273492

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

NCT02273492 ↗

Phase 1 Completed 28 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Comparative pharmacokinetics and pharmacodynamics of Asasantin ER at fasted and fed state

Timeline

Start
1999-08
Primary completion
1999-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Asasantin ER Unknown — —

Indications

No indication recorded.